White Paper: A Standardised Protocol for Life Force Quantification using the CTC Formula as a Foundational Algorithm

 

Dr Gordon Slater^* and Toni Worrall

Citation: Slater G, Worrall T. White Paper: A Standardised Protocol for Life Force Quantification using the CTC Formula as a Foundational Algorithm.  J Stem Cell Res. 7(2):1-16.

Received: June 30, 2026 | Published: July 16, 2026

Copyright^© 2026 by Slater G, et al. All rights reserved. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

DOI: https://doi.org/10.52793/JSCR.2026.7(2)-89

Abstract

Extension of life and health span is a cornerstone of modern scientific research. This paper explores the Chaos to Creation (CTC) formula, proposed in Dr Gordon Slater’s book Chaos to Creation, as a theoretical framework for understanding the variables that may moderate health span, drawing inspiration from Newton's second law and Einstein's mass-energy equation. Regenerative strategies across five organisms are compared and evaluated for their translational relevance to human biology, suggesting that meaningful extension of human health span may require a combinatorial approach. Future directions for this framework include the quantification of each variable empirically through the isolation of relevant biomarkers and the application of this framework to create testable hypotheses of health span.

Keywords

Aging; Hallmarks of Aging; Mathematical Modelling; Lifespan; Longevity; Regeneration; Stem Cells.

Introduction

Delaying death

In 1800, the global average life expectancy was about 30 years, and in the early 2000s it became 66.6 years, with an average yearly life expectancy gain of 0.19 years per year. Gains in life expectancy began in the 1890s in Western Europe, the United States and Australia. Many factors, including the introduction of sanitation and clean water and waste disposal systems are credited with these original changes [1,2]. In most other countries, 'health transitions' began around 1920 with a further sharp jump in the late 1940s due to the introduction of antibiotics and modern vaccines [2]. Now, life expectancy sits above 80 in many parts of the world as the approach to conditions such as infectious diseases, cardiovascular conditions and cancer improves.

However, as lifespan increases, so does the length of time that many individuals experience chronic disease or disability such as osteoarthritis or Alzheimer's disease [3,4]. Unfortunately, an expansion of lifespan in many individuals has not led to an extension of health span, and this widening period of chronic disease and functional decline has led to a reduced quality of life and increased healthcare expenditure.

If life expectancy continues to increase at such a rate, interventions to address the causes of these chronic diseases and disability are essential to ensure that people can live longer and healthier lives [4]. To do so, drivers of aging must be further understood so that health can be prolonged in a sustained and effective manner. If therapeutic agents or protocols can be isolated to target, and even reverse, aging, many of these illnesses could be eliminated [3].

But first, the parameters must be defined. Is extending lifespan the ultimate goal? Or is it more valuable to compress morbidity; to live the same number of years, but in better health for longer? And if health span can be significantly extended, is there an ideal way to do so?

The hallmarks of aging

The key domains of aging research, known as the Hallmarks of Aging, include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion and altered intercellular communication [5]. Many of these hallmarks are related to the repeated division of cells, each replication cycle introduces opportunities for mutation accumulation, telomere shortening, epigenetic drift, and eventual exhaustion of stem cell pools [5]. In this sense, the mechanism by which organisms grow, repair and sustain themselves also drives their progressive decline, a tension that any therapeutic strategy targeting aging must address.

Genomic instability is the first hallmark, as DNA can be damaged by endogenous factors such as replication errors in addition to exogenous factors like environmental toxins and UV radiation [6]. Telomere attrition is another hallmark, where telomeres, which regulate genomic instability by acting as protective caps at the end of chromosomes, become shorter after cell division [7,5]. Without this protection, the odds of mutation increase, often leading to tumorigenesis [7]. Next, epigenetic alterations including modification of histones post-translation, remodelling of chromatin, and DNA methylation changes can occur. Internal and external factors can express or inhibit genes and, as aging occurs, more harmful genes can be expressed and genes that protect from harmful pathways may be silenced [5].

A loss of proteostasis is another hallmark of aging, with research suggesting that an increase in age-related protein formation changes such as repeated expression of misfolded, aggregated or unfolded proteins has been linked with age-related illnesses such as Parkinson's and Alzheimer's disease [5]. Deregulated nutrient sensing, altering the functions of growth hormone and insulin-like growth factor (IGF-1), has also been linked with longevity, with many studies demonstrating that dietary restriction can increase health span in many species [5,8].

The sixth hallmark of aging, mitochondrial dysfunction, is commonly characterised by reduced generation of ATP and increased electron leakage, due to a reduction in the efficiency of the respiratory chain. This can also lead to an increase in reactive oxygen species (ROS) production, which exacerbates mitochondrial deterioration and cellular damage globally [5].

Similarly, cellular senescence, which is an arrest of cell division that works to avoid the development of malignant cells or apoptosis, has been linked to aging and a reduction in health span. This is because continued activation of this pathway can also contribute to tumorigenesis and other pathological conditions [9]. Therefore, the accumulation of senescent cells is another key hallmark of aging [5]. Stem cell exhaustion, or a decline in the regenerative capacity of tissues, is another well-known hallmark [5]. Finally, altered intercellular communication and signalling can reduce immunosurveillance against premalignant cells and increase inflammatory reactions, which are common age-related characteristics [5].

These hallmarks of aging are interconnected and interdependent, making aging a complex and multifactorial process that is difficult to target through existing therapeutic strategies. However, these hallmarks can be targeted before they begin to express themselves in physical forms of aging, this may permit the extension of the health span, and subsequently, lifespan.

Mathematical modelling in physics and biology

Mathematical modelling has been used to make sense of countless phenomena in disciplines such as physics, chemistry and biology. A prime example of this is Newton's laws of motion, which include three laws outlining how an object's motion is related to the forces that act upon it. Newton's second law of physics, f = ma, introduces three key variables: force = f, mass = m, and acceleration = a [10]. This equation demonstrates how constant force does not equate to constant speed and how mass directly opposes the acceleration of an object [11]. These principles have been applied in other disciplines such as biology. For example, Stokes flow equations provide a system for conducting fluid dynamic calculations, and Laplace tension equations borrow Newtonian principles and apply them to cell membranes [12,13].

Inertial principles have also been used to characterise biological states, with Soto et al [14]. referencing Galileo's analysis of inertial movement to propose a default biological state of cell proliferation. Soto argued that because many experiments have created conditions that closely mirror unrestricted proliferation of cells, proliferation, variation and motility should be perceived as their default state. If this were true, then only departures from this default state would need to be investigated, simplifying cell research [14]. This was likened to inertial theories, as accepting inertia as a principle means that researchers do not have to explain 'uniform rectilinear motion' but rather cases where it does not occur due to forces such as gravity or friction [15,14]. Therefore, when quantifying the Life Force of an individual, is there a peak life and health span much longer than currently observed in humans? Should chronic degeneration and death be investigated as departures from the default?

Another equation integral to mathematics and physics is Einstein's famous equation, E = mc², where e = energy, m = mass and the c = speed of light. This equation equates mass and energy, with c² acting as a proportionality constant between the two, demonstrating how a small amount of mass can be converted into enormous amounts of energy [16]. This equation can be related to many biological processes including bioenergetic mechanisms, which maintain cellular homeostasis. Food or other sources of energy act as mass, which is converted into energy (e.g. ATP molecules), sustaining many vital functions such as metabolic processes and cellular respiration [17].

Mathematical Modelling of Life Force

Like other biological processes, mathematical modelling can be used in regenerative medicine to predict the behaviour of senescent cells and other hallmarks of aging as well as how various regenerative strategies could be used to target them. However, one of the main challenges is to identify where mathematical modelling can provide the most benefits and to determine how to operationalise variables related to regeneration and aging [18].

This paper will discuss the application of the Chaos to Creation formula, introduced in Dr Gordon Slater’s book Chaos to Creation, as a novel characterisation of the aging process. The variables within these equations include predicted total Life Force ( ) in years, Vectergy - the total directed biological energy available for reversal ( ) in Joules (J), Annual Regenerative and Degenerative capacity (R) and (D) per year, Biological Inertia; total accumulated energy barrier (I), and Stem Addition; direct longevity bonuses from all advanced therapies in years (Table 1) [6].

Figure 1: Life Force Equation.

This model is mechanistic and continuous, with smooth variables that vary fluidly over time, rather than those representing individual cells and interactions [18]. If successfully defined, it could be used to clinically optimise regenerative therapy by understanding the trade-offs between degeneration and regeneration to enhance and extend health span and longevity.

Understanding life force

A simplistic understanding of Life Force ( ) would be that it peaks at conception and cellular creation, as it represents the maximum potential for someone to live another year. It begins to gradually decline as the hallmarks of ageing begin to accumulate and age-related diseases begin to express themselves, such as arthritis and osteoporosis [19]. Finally, at death, Life Force could be thought to approach 0 or become negative, representing the system’s inability to counteract the Biological Inertia and Degenerative Rate that has progressively increased over multiple decades.

However, this definition is complicated by alternative scenarios, for example, the HeLa cell line. The HeLa cell line, derived from a cancerous cervical tumour, taken without consent from Henrietta Lacks, illustrates this complication vividly; whilst Henrietta passed away from cancer in the 1950s, these cells continue to proliferate in laboratories today, contributing to the development of the polio vaccine and advancing understanding of cancer, radiation biology, and viral pathogenesis [20]. If Life Force is equated with biological vitality alone, the HeLa line never reached zero, persisting decades beyond Henrietta’s death. This paradox suggests that a binary conception of Life Force as present until death, is insufficient. Instead, Life Force must be understood as a dynamic and distributed property, one that does not simply switch off at death but may persist or transform in response to shifts in biological states.

To define Life Force, it can be examined at its theoretical boundaries. At birth, an organism enters the world with maximal regenerative potential: stem cell populations are abundant, telomere length is at its greatest, and inflammation is minimal [5]. However, the Australian Institute of Health and Welfare recorded the lowest number of deaths in the 5–9 age cohort (111 deaths) and the second lowest in the 10–14 cohort (121 deaths) across 2024, suggesting that biological resilience peaks in early to mid-childhood rather than immediately at birth, before a gradual decline begins [21].

Life Force, understood at these extremes, appears like a gradient, ascending steeply in early development, plateauing across the prime years, and declining as Regenerative Capacity is outpaced by the accumulation of various hallmarks of aging. Acute illness, injury, psychological stress, or therapeutic intervention may accelerate or temporarily reverse the curve at any point. Similarly, whilst time is treated as a constant within this framework, progressing uniformly for all individuals, the rate at which biological aging tracks against chronological age varies considerably between individuals. Life Force, in this sense, is less a clock than a cumulative biological state, and it is that state, rather than years elapsed, that the CTC formula seeks to capture.

Given these complexities, this paper proposes a pivot from Life Force as an analogue to lifespan, towards Life Force as a measure of health span: the duration and quality of life characterised by functional integrity, regenerative capacity, and freedom from chronic disease. This reframing is supported by evidence in connective tissue biology, where the progressive degradation of articular cartilage can compress health span well before mortality [22]. Comparative biology reinforces this argument, species such as the naked mole rat and the Greenland shark maintain exceptional health span relative to their lifespans through mechanisms including superior DNA repair, resistance to oxidative stress, and sustained proteostasis.

The central question this paper therefore addresses is not just how many years an organism lives, but how robustly it lives them, and what biological strategies, preserve or restore their vitality.

Vectergy, regenerative capacity, degenerative rate, biological inertia and stem addition

Parallels can be seen with Newton's second law, where Vectergy ( acting as the driving force behind life. Vectergy allows the acknowledgement that a cell can have large amounts of energy but not exhibit a regenerative direction (such as in cancer cell proliferation), or it could have directional signals but lack sufficient energy (such as in senescent cell accumulation). The expression of Vectergy as a vector emphasises the importance of both abundant energy and the correct directional signals to amplify health and lifespan.

The net regenerative term R – D acts as the 'mass-like' regenerative substrate, ready to be translated in either direction. It reflects the current state of the biological field; when Degenerative Rate exceeds Regenerative Capacity, this ratio falls, meaning that even sufficient mass cannot generate the Life Force required to accelerate it. Stem cells are a component of Regenerative Capacity could be seen to mirror the speed of light in Einstein's equation, acting as a high-impact converter used to unlock enormous amounts of regenerative 'energy'. However, declining stem cell density and function, as seen in conditions like osteoarthritis, has the opposite effect, leading to accelerated degeneration. This relationship may explain why stem cell therapies can achieve a much larger effect in 'low-inertia conditions' such as acute injuries, when compared to 'high-inertia conditions' seen in chronic degeneration [23].

Biological Inertia similarly moderates the 'mass', resisting the force enacted by Vectergy. It is important as it helps to acknowledge the reduction in regenerative potential as the aging process continues, normalising the net regenerative term. Stem Addition ( ) provides a boost to life, amplifying the rate of regenerative change. Stem Addition is achieved through regenerative therapies including stem cell therapy, hyperbaric oxygen therapy and targeted anti-inflammatory strategies, and does not refer to endogenous stem cells, as they are included in the Regenerative Capacity variable.

The Chaos to Creation Equation draws structural inspiration from foundational equations in physics, treating biological aging as a dynamic system governed by force-like and inertial principles. Just as Newton's second law describes how a force applied to a resistant mass produces acceleration, the Life Force Equation describes how directed biological energy, Vectergy, acts on the body's regenerative term against the resistance of Biological Inertia. This could explain why two individuals with equivalent energy reserves can exhibit vastly different functional capacity: the one burdened by greater accumulated Biological Inertia perhaps due to toxin accumulation and cellular senescence, must expend far more Vectergy to achieve the same Life Force. Similarly, Einstein's equation captures the principle that stored energy can be converted into enormous functional output, a principle echoed in the disproportionate regenerative impact of stem cell therapies when Biological Inertia is low. Vectergy unifies these ideas, representing not merely the quantity of available biological energy, but the degree to which it can be directed toward regeneration. When Degenerative Rate exceeds Regenerative Capacity, or when Biological Inertia accumulates unchecked, this direction is progressively lost and Life Force approaches zero.

CTC Formula in Various Organisms

Hydra

Animal life is commonly considered as a straight unidirectional line, beginning at embryological development and passing through maturation, reproduction, senescence and death [24]. Distinctions between animals and plants have often included the pluripotency and self-renewal capacity retained by most plants [25]. However, in some animals, particularly those in the Cnidaria phylum, the lines between development and regeneration are blurred, as demonstrated in Trembley's pivotal experiments, where a bisected Hydra polyp was shown to generate two new animals [27]. Further research has demonstrated that a piece of Hydra tissue consisting of more than 300 cells can become a new animal through morphallaxis, where the cells alter their morphology to construct an entirely new being [24]. Even after Hydra cells are suspended and centrifuged, they have been shown to reaggregate into polyps [28].

Due to these discoveries, Hydra stem cells have been extensively studied. Researchers have found that these cells have continuous and lifelong proliferation. Whilst the underlying mechanism is still not completely understood, a link between capacity for self-renewal and cell cycle length has been established [25]. Unlike most animals, this regenerative capacity is not limited to individual organs or tissues [26]. This capacity is akin to plants, which contain meristems consisting of undifferentiated cells that can be used for leaf regeneration [29].

In the context of the CTC formula, Regenerative Capacity can be seen as 'unbounded' for the Hydra, as there is no observed endpoint where it declines, if metabolic constraints such as energy, food and space do not exist. The inverse relationship between stem cell function and Biological Inertia can be clearly illustrated through comparison of the Hydra and humans.

This supports recent research into age-related declines in mesenchymal stem cells in humans, which have been shown to have a strong relationship with the prevalence of degenerative diseases such as cancer, osteoarthritis and cardiovascular disease [30]. This explains why exogenous stem cell therapies perform better when treating acute injuries rather than chronic conditions, where accumulated resistance gradually limits their therapeutic abilities [23]. It also raises the possibility that strategies using stem cells could represent a particularly potent method for health span extension.

The Hydra’s regenerative strategy does not merely extend duration, it shows no evidence of functional decline preceding death, suggesting that its Life Force is sustained at a consistently high level rather than simply prolonged in a diminished state [31]. Its perpetually replenished stem cell population ensures that Biological Inertia never meaningfully accumulates, forestalling the inertial resistance that, in other organisms, accumulates irreversibly over time. Within the health span framing of this paper, the Hydra represents a system in which health span and lifespan are effectively the same.

Whale

Whilst the Hydra is a prime example of how biological systems can achieve near-infinite Life Force with through a high Regenerative Capacity and reduced Biological Inertia, it has a simple morphology, lacks organs and is separated from humans by approximately 600 million years of evolution [25]. Whales, whilst distinctly physically different to humans, are mammals, sharing numerous physiological and anatomical characteristics including a four-chambered heart, a similar bone composition, and homologous brain structures associated with social and emotional cognition [32,33]. As placental mammals, whales also share reproductive similarities with humans, including gestation, live birth, and lactation [34].

It is commonly assumed that more cells equate to a higher chance of cancer due to more opportunities for mutation to accumulate, given that all cells have an equal probability of developing mutations [35].  This was explored by Calabrese & Shibata in 2010, where the probability of colon cancer was expressed in an algebraic equation:

p = 1 − (1 − (1 − (1 − u)d)k)Nm

Where d = number of divisions, Nm = number of stem cells, k = number of "critical rate-limiting pathway driver mutations", u = mutation rate.

This equation demonstrates how increases in cancer prevalence with age can be caused by generally normal rates of division and mutation [36]. This concept is also referred to as the ‘perils of division’, referenced throughout the Chaos to Creation book, as every cell division provides multiple opportunities for error, for example through the accumulation of mutations, telomere attrition, epigenetic drift and mitotic errors [5,6].

However, according to this equation, all blue whales should have colorectal cancer by the age of 80, which is improbable considering some blue whales have a lifespan of longer than 100 years. This indicates that there are distinct differences in the development and progression of cancer in larger animals when compared to humans. This absence of a correlation between longevity, body size and cancer is commonly known as Peto's paradox [35,37].

Recent research has also uncovered an inverse relationship between lifespan and somatic mutation rates, which is supported by studies reporting a higher DNA repair capacity in animals with longer lifespans such as bowhead whales [38,39]. Research conducted by Tejada-Martinez et al. (2021) also demonstrated that the tumour suppressor gene turnover rate in cetaceans was more than two times higher than in other mammals. Larger organisms also have characteristics that may confer tumour suppression abilities, including decreased ROS production due to their reduced basal metabolic rate [35].

However, some studies argue that no such paradox exists and that larger animals exhibit a greater cancer prevalence than smaller ones [40]. Further research must be conducted to understand the connection between body size, lifespan and cancer susceptibility, to perhaps harness the cancer suppression mechanisms seemingly conferred by some animals.

Parallels to the longevity of the blue whale can also be drawn with the CTC formula. The blue whale sits almost at the opposite end of the spectrum to the Hydra, as the largest known animal with a lifespan of more than 100 years, indicating a large Biological Inertia to overcome and a moderate Regenerative Capacity [41]. The blue whale also has a low metabolic rate and a gradual rate of degeneration over time, resulting in a low overall net regenerative mass [35]. However, the large Vectergy stemming from its enormous energy throughput, for example, consuming up to 16 tonnes of krill a day, could be seen as the driving factor, or acceleration, for the longevity of the blue whale [42]. Within the CTC formula, this sustained energetic input could be interpreted as compensating for the blue whale's high Biological Inertia, maintaining a Life Force sufficient for a century-long lifespan.

Greenland shark

The Greenland shark is the longest-living vertebrate known, with lifespan estimates exceeding 400 years based on radiocarbon dating of eye lens proteins [43]. This extreme longevity is thought to be supported by several interrelated biological traits, including an exceptionally slow metabolism, cold-adapted physiology, and strong cellular maintenance mechanisms. Living in extremely cold waters, the Greenland shark’s metabolic rate is among the lowest recorded for any vertebrate, with an average of less than one centimetre of growth a year and delayed reproductive maturity, often reached only after 150 years [44,43,45].

It is thought that the Greenland shark’s low body temperature and slow metabolism may reduce the accumulation of somatic mutations, oxidative stress, and protein misfolding, all of which contribute to aging and cancer susceptibility. Genomic and proteomic studies have revealed that the Greenland shark possesses adaptations related to protein stability, DNA repair, tumour suppression, and oxidative stress tolerance, suggesting a molecular basis for its resistance to aging and disease [46,47]. Lens proteins are metabolically inert after embryonic formation, receiving no turnover or replacement throughout life. This means that their structural integrity over four centuries provides empirical evidence of the shark's protein stability mechanisms, beyond their utility as a dating tool [43]. This is because, in most vertebrates, proteins often accumulate damage, crosslinks, and aggregation that contribute to tissue dysfunction [5]. The mechanisms underpinning the Greenland shark's longevity appear to preserve functional capacity across centuries rather than simply extending a period of senescence. Protein stability, reduced oxidative damage, and sustained tumour suppression suggest that degeneration is maintained at a low level, leading to an extended Life Force as well as lifespan.

Within a Life Force framework, the Greenland shark represents a distinct longevity strategy alongside the Hydra’s enhanced Regenerative Capacity. It leverages its Biological Inertia, which is considered a liability in other organisms, to its advantage. At near-freezing temperatures, enzymatic reaction rates are substantially reduced, slowing the accumulation of somatic mutations, oxidative damage, and protein misfolding at a rate that outpaces equivalent mechanisms in warmer-bodied vertebrates [44,46].

Furthermore, the delay in reproductive maturity reflects an evolutionary prioritisation of somatic maintenance over reproduction, representing one of the most extreme demonstrations of Kirkwood's disposable soma theory [48,43]. This theory posits that longevity is often the product of a compromise between reproductive investment and somatic maintenance [48]. The result is a system where Vectergy demands are extraordinarily low, Degenerative Rate approaches near zero, and Regenerative Capacity, while not extraordinarily high, remains steady over centuries.

Tortoise

Giant tortoises are the longest living land vertebrates, which paradoxically exhibit little evidence of age-related decline [49,50]. Gene sequencing has revealed that turtles have genomic changes that may elevate immunosurveillance of pre-malignant cells and protect against hallmarks of aging such as genomic instability, telomere attrition, and mitochondrial dysfunction [50]. Tortoises also continue growing after they reach reproductive maturity, which may help them to avoid the accumulation of senescent cells [49]. Many studies have also linked the slow metabolic rates in tortoises to their increased longevity due to a reduction in cell damage [51].

Approximately 80% of tortoises and turtles exhibit aging rates slower than humans [49]. The extreme biological efficiency of tortoises appears to be the driving factor behind their extended health span and longevity. Whilst they only have a moderate Regenerative Capacity, reduced stem cell exhaustion and senescence may contribute to a larger Life Force. This means that whilst the Hydra's regenerative strategy could be seen as overwhelming the system with a high Regenerative Capacity despite a high metabolic cost, the tortoise maintains its life and health span by minimising subtraction through near-zero degeneration, with an extremely low metabolic cost, leading to a long-lasting, elevated Life Force.

Naked mole rat

The naked mole rat is another commonly studied animal due to its lifespan of 37 years, more than eight times the lifespan of mice of a similar size [52]. It has been described as a non-aging animal, with the reasons behind its eventual death currently unknown. Age-related physiological declines such as menopause, reductions in cardiac function, bone quality and metabolism have not been reported in the naked mole rat. Additionally, research has suggested that age-related mortality does not increase with age [53].

Research into the biological mechanisms of this longevity has indicated that the naked mole rat has an elevated capacity to address oxidative stress exerted on mitochondria and the resultant cellular senescence [54]. Other studies have also demonstrated their resistance to tumorigenesis and retention of genomic stability with age in comparison to other rodents with shorter lifespans [55]. In 2023, researchers modestly improved the healthspan of mice by transferring a gene abundant in the naked mole rat, high-molecular-mass hyaluronic acid (HMM-HA) [56]. The researchers observed a reduction in inflammation through multiple pathways, including increasing oxidative stress protection and improving gut barrier function [56]. These findings suggest that regenerative strategies from other animals can be harnessed to improve Life Force.

This research suggests that a reduced Degenerative Rate and Biological Inertia in the naked mole rat play a key role in its elevated Life Force. This is achieved by actively combating degeneration rather than minimising it through a reduced metabolic cost. It fights degeneration through its elevated ability to manage oxidative stress, cancer resistance and robust DNA repair and maintenance. Of all the organisms examined in this paper, the naked mole rat provides the most direct evidence for health span extension independent of lifespan. The absence of age-related physiological decline across its 37-year lifespan suggests that its damage interception mechanisms preserve functional integrity rather than just delaying death.

This strategy varies from that of the Greenland shark who achieves Life Force extension by reducing the rate at which damage occurs rather than having superior mechanisms to fight it. These represent two fundamentally distinct biological solutions to the same problem of cumulative cellular damage, and their comparison may offer complementary insights for longevity research.

Humans

As humans age, they become more vulnerable to degeneration and less effective at healing [29]. The regenerative capacity of humans is highly specific; for example, whilst humans generally cannot regenerate limbs that have been severed, they do have the capacity to regenerate liver, blood and skin [29]. Additionally, research has demonstrated the regenerative capacity of the fingertip in children under the age of eleven, however, this capacity has not successfully been understood or replicated in non-regenerative parts of the body [57,58]. Similarly, infrequent instances of complete regeneration have also been noted in adults [59].

Biological Inertia and Degenerative Rate increase with age, whilst Regenerative Capacity and Vectergy decrease, leading to a constantly diminishing Life Force. However, these processes are not linear, which is represented by the relationship between the variables in The Chaos to Creation formula.

When compared to the organisms discussed above, the human regenerative profile is characterised by a moderate Degenerative Rate, high Biological Inertia, and a moderate but rapidly declining Regenerative Capacity. Unlike the Hydra, humans do not retain pluripotent stem cell populations capable of whole-body regeneration throughout their lifespan; and unlike the tortoise or naked mole rat, humans do not possess the metabolic or genomic stability to slow the accumulation of cellular damage over time [60,29]. Placental mammals as a group appear to have undergone a broad suppression of regenerative potential during early development, with scarless tissue repair largely restricted to the foetal period in humans [61]. This suggests that regenerative potential may be latent rather than absent in adult human tissue, raising the possibility that targeted reactivation of these pathways could restore some regenerative capacity [62].

This superior regenerative ability observed in infants is known as the foetal healing capacity, with studies of the infant healing processes observing a reduction in inflammatory processes commonly found in adult healing. Similarly, foetal inflammatory cells have also been found to be less differentiated, permitting differentiation into specific cells required by the healing process when needed [63].

Humans therefore represent a unique challenge within the CTC formula: the high Biological Inertia of an organism with complex organ systems, combined with a relatively short regenerative window. This means that therapeutic leverage must be applied early and consistently to meaningfully shift the Life Force trajectory. The comparative evidence from Hydra, tortoise, and naked mole rat suggests that no single strategy is sufficient. Instead, a combined approach simultaneously boosting Vectergy, reducing Degenerative Rate, and providing Stem Addition through various therapeutic strategies may be required to produce meaningful extension of human health and lifespan [29].

Regenerative Strategies for Life and Health Span Extension

The Chaos to Creation formula provides a novel lens for regenerative medicine. Its structural and conceptual similarities to fundamental scientific equations such as E = mc² and F = ma highlight the strong theoretical basis of this framework. The equation treats biology as a dynamic system governed by force-like and inertial principles, pushing the field further towards predictive, quantitative science.

Einstein's theory of relativity demonstrates that time is not a fixed constant but a malleable dimension, capable of being altered by factors such as velocity and gravitational fields [64,65]. Examples of this can be seen in the Hafele-Keating experiment, where atomic clocks flown on commercial aircraft measured measurable differences in elapsed time compared to stationary clocks, confirming the velocity-based and gravitational time alterations predicted by relativity [66].If time can be altered by physical and environmental factors, this invites a similar question for biological aging: might the rate at which organisms age also be susceptible to manipulation by seemingly unrelated factors?

Evidence from this paper suggests this may already be occurring. The Greenland shark's thermal environment, the naked mole rat's oxidative stress management, and the tortoise's metabolic architecture each seem to decouple chronological age from biological age in ways conceptually similar to relativistic effects on time [46,54,49]. This draws on relativity as a conceptual precedent rather than a literal equivalence: that seemingly fixed biological processes may be manipulated when the right variables are identified and targeted.

The diversity of regenerative responses across animals is moderated by a complex interaction of metabolites, transcription factors, structures and signalling molecules [29]. Regenerative Capacity varies greatly between animals, and long health and lifespans have been achieved by multiple organisms harnessing varied regenerative strategies.

The organisms examined in this paper demonstrate that extended health and lifespan can be achieved through multiple distinct biological strategies: optimal Regenerative Capacity, seen in the Hydra's unbounded stem cell proliferation; passive degenerative minimisation, demonstrated in the tortoise's metabolic suppression and the Greenland shark's thermodynamic constraint; and active damage interception, as shown in the naked mole rat's molecular damage response systems.

Whilst the Hydra's strategy produces the highest theoretical Life Force by maximising Regenerative Capacity, it is the least translatable to human biology given the fundamental suppression of pluripotent regenerative capacity in placental mammals during early development [61]. The passive strategies of the tortoise and Greenland shark, whilst effective, depend on ectothermic or cold-adapted physiologies incompatible with human homeothermy. The naked mole rat's active interception strategy may represent the most realistically translatable framework for human intervention, with damage suppression via oxidative stress management, proteostasis maintenance, and tumour suppression offering clinical targets [56,54].

As established, extension of human lifespan has not been matched by equivalent gains in health span, with an expanding period of chronic disease and functional decline now documented across multiple populations [4,67]. Within the CTC formula, this mismatch can be understood as a failure to sufficiently reduce Degenerative Rate and Biological Inertia before they accumulate beyond a recoverable threshold. Meaningful compression of morbidity may therefore require intervention well before the hallmarks of aging become apparent, potentially through Stem Addition via hyperbaric oxygen therapy, anti-inflammatory strategies and targeted stem cell therapies.

Identification and quantification of the variables that could extend health span is the primary objective of this framework. Once accurately measured, it may become possible to isolate limiting factors and target them to extend health span and potentially lifespan.

Future Directions

Future directions include the quantification of each term empirically using biomarkers and validation through longitudinal trials. Additionally, once each variable in The Chaos to Creation formula can be measured, a synthetic model can be developed, that treatments aiming to extend health span can be tested against. Comparative studies across different types of applications and clinical contexts will be essential to determine the generalisability and translational potential of The Chaos to Creation framework.

A critical next step is the identification and validation of biomarkers capable of quantifying each variable in the CTC formula. Vectergy, as a measure of directed biological energy, may be approximated through markers of mitochondrial efficiency such as NAD+/NADH ratios, ATP production rates, and measures of oxidative phosphorylation capacity [68,69]. ROS levels and mitochondrial membrane potential could act as inverse indicators, reflecting energy leakage reducing net Vectergy [5].

Regenerative Capacity and Degenerative Rate may be captured through complementary biomarkers. Circulating mesenchymal stem cell counts, Ki67 expression as a marker of cell proliferation, and tissue-specific growth factor concentrations (e.g. IGF-1, HGF) could indicate regenerative capacity [70,71]. Degenerative Rate may be measured through established senescence markers such as p16 and p21 expression, the senescence-associated secretory phenotype (SASP) cytokine elevation, and telomere attrition rates [72,73].

Biological Inertia, representing the accumulated resistance to regenerative change, is perhaps the most complex variable to measure directly. Epigenetic age clocks such as the Horvath clock, alongside measures of genomic instability and DNA methylation entropy, may provide a composite proxy for the extent to which a biological system has drifted from its regenerative default [74]. GrimAge2 has also been proposed as a biomarker for human mortality risk, based on DNA methylation [74]. This biomarker could be used among other biomarkers as an empirical measurement of Biological Inertia.

Longitudinal tracking of these biomarker panels across diverse populations and in response to regenerative interventions will be essential for validating the predictive ability of The Chaos to Creation model in clinical settings. The accuracy and validity of the biomarkers chosen for each term can be determined through application of the equation to well-known and varied cases such as the Hydra, tortoise, naked mole rat, whale and human.

The framework's immediate usefulness lies in hypothesis generation and clinical prioritisation. Its longer-term value depends on the empirical quantification of each variable through validated biomarker panels, and on longitudinal trials capable of detecting shifts in the Life Force trajectory in response to intervention. The organisms examined here, from the effectively non-aging Hydra to the metabolically constrained Greenland shark, demonstrate that biology has already solved versions of this problem. Once these variables are defined, the task for translational medicine is to determine which solutions are compatible with human physiology, and to deploy them before the hallmarks of aging accumulate beyond a recoverable threshold, with the intention of significantly extending health span.

References

1. Gallardo‐Albarrán D. (2024). The global sanitary revolution in historical perspective. J Eco Surveys.
2. Riley JC. (2005) The Timing and Pace of Health Transitions around the World. Pop Dev Rev. 31(4):741-44.
3. Couteur DGL, Barzilai N. (2022) New horizons in life extension, healthspan extension and exceptional longevity. Age Ageing. 51(8).
4. Crimmins EM, Beltran-Sanchez H. (2010) Mortality and Morbidity Trends: Is There Compression of Morbidity? J Gerontol Series B: Psychol Sci Soc Sci. 66B(1):75-86.
5. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. (2013). The Hallmarks of Aging. Cell. 153(6):1194-217.
6. Slater GL. (2026) From Chaos to Creation. Integrant.
7. Iskandar M, Barbero MX, Jaber M, Chen R, Gomez-Guevara R, et al. (2025) A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches. Cancers. 17(2):257.
8. Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AM, et al. (2012) Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 489(7415):318-21.
9. Ajoolabady A, Pratico D, Bahijri S, Eldakhakhny B, Tuomilehto J, et al. (2025) Hallmarks and mechanisms of cellular senescence in aging and disease. Cell Death Disc. 11(1).
10. Hill JM. (2024) Newtonian laws of motion and conservation principles. Mathematics Mechanics of Solids.
11. Mochrie S, De Grandi C. (2023) Introductory Physics for the Life Sciences. Springer Nature.
12. Chao PC, Sachs F. (2021) Membrane tension. In Current Topics in Membranes. 189-203. Elsevier.
13. Gallagher MT, Smith DJ. (2020) Passively parallel regularized stokeslets. Philosophical Transactions of the Royal Society A. 378(2179):20190528.
14. Soto AM, Longo G, Montévil M, Sonnenschein C. (2016). The biological default state of cell proliferation with variation and motility, a fundamental principle for a theory of organisms. Prog Biophy Mole Bio. 122(1):16-23.
15. Bussotti P, Pisano R. (2024) Details in Galileo's Mechanism of Inertia as New Intellectual Historical Insights. History Mechanism Machine Science. 503-60.
16. Hewitt P. (2016) Focus on Physics: How E = mc2 Helps Us Understand Nuclear Fission and Fusion. The Science Teacher. 083(09).
17. Granath-Panelo M, Krook A, Rutter J, Kajimura S. (2023) On the cutting edge: perspectives in bioenergetics. Nature Rev Endo. 19(5):250-51.
18. Waters SL, Schumacher LJ, El Haj AJ. (2021) Regenerative medicine meets mathematical modelling: developing symbiotic relationships. Npj Reg Med. 6(1):1-8.
19. Cox LS. (2022) Therapeutic approaches to treat and prevent age-related diseases through understanding the underlying biological drivers of ageing. J Eco Ageing. 23:100423.
20. Khan FA. (2011) The immortal life of Henrietta Lacks. J Islamic Me Ass North Am. 43(2):93-94.
21. Australian Institute of Health and Welfare. (2024) Deaths in Australia, Age at death. Australian Institute of Health and Welfare.
22. Heir S, Nerhus TK, Røtterud JH, Løken S, Ekeland A, et al. (2010) Focal Cartilage Defects in the Knee Impair Quality of Life as Much as Severe Osteoarthritis. Am J Sports Med. 38(2):231-37.
23. Murphy MB, Moncivais K, Caplan AI. (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Experimental Mole Med. 45(11):e54.
24. Gold DA, Jacobs DK. (2012) Stem cell dynamics in Cnidaria: are there unifying principles? Dev Genes Evo. 223(1-2):53-66.
25. Holstein TW. (2023) The Hydra stem cell system – Revisited. Cells Dev. 174:203846.
26. Tursch A, Holstein TW. (2023) From injury to patterning—MAPKs and Wnt signaling in Hydra. Current Topics in Dev Bio. 381-417.
27. Lenhoff HM, Lenhoff SG. (1988) Trembley's Polyps. Scientific Am. 258(4):108-13.
28. Bosch TCG. (2007) Why polyps regenerate and we don't: Towards a cellular and molecular framework for Hydra regeneration. Devel Bio. 303(2):421-33.
29. Sasidharan V, Alvarado AS. (2021) The Diverse Manifestations of Regeneration and Why We Need to Study Them. Cold Spring Harbor Perspectives in Biology. 14(9):a040931.
30. Slater GL, Wu C. (2025) Age-Related Decline in Mesenchymal Stem Cells: Implications for Degenerative Disease Burden and Regenerative Medicine Strategies. PriMera Sci Surg Res Practice.
31. Mas-Bargues C. (2025) Translating lessons from immortal models: Hydra and the immortal jellyfish. Revista Española de Geriatría Y Gerontología. 60(4):101624.
32. Fox KCR, Muthukrishna M, Shultz S. (2017) The social and cultural roots of whale and dolphin brains. Nature Ecology & Evolution. 1(11):1699-705.
33. Meijler FL, Meijler TD. (2011) Archetype, adaptation and the mammalian heart. Netherlands Heart J. 19(3):142-48.
34. Pyenson ND. (2017) The Ecological Rise of Whales Chronicled by the Fossil Record. Current Bio. 27(11):R558-R564.
35. Caulin AF, Maley CC. (2011) Peto's Paradox: evolution's prescription for cancer prevention. Trends in Ecology & Evolution. 26(4):175-82.
36. Calabrese P, Shibata D. (2010) A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates. BMC Cancer. 10:3
37. Uzoigwe CE. (2025) Peto's paradox: 2 problems 2 answers. Fronti Ecology Evo. 13.
38. Cagan A, Baez-Ortega A, Brzozowska N, Abascal F, Coorens THH, et al. (2022) Somatic mutation rates scale with lifespan across mammals. Nature. 604(7906):517-24.
39. Firsanov D, Zacher M, Tian X, Sformo TL, Zhao Y, et al. (2025) Evidence for improved DNA repair in long-lived bowhead whale. Nature.
40. Lynch VJ. (2025) Peto's paradox revisited (revisited, revisited, revisited, and revisited yet again). Proceedings of the National Academy of Sciences. 122(14).
41. Breed GA, Vermeulen E, Corkeron P. (2024) Extreme longevity may be the rule not the exception in Balaenid whales. Sci Adv 10(51).
42. Smithsonian. (2025) The Tons that Whales Eat...and Poop | Smithsonian Ocean. Ocean.si.edu.
43. Nielsen J, Hedeholm RB, Heinemeier J, Bushnell PG, Christiansen JS, et al. (2016). Eye lens radiocarbon reveals centuries of longevity in the Greenland shark (Somniosus microcephalus). Sci. 353(6300):702-04.
44. Ste-Marie E, Watanabe YY, Semmens JM, Marcoux M, Hussey NE. (2022) Life in the slow lane: Field Metabolic Rate and Prey Consumption Rate of the Greenland Shark (Somniosus microcephalus) modeled using Archival Biologgers. J Exper Bio.
45. Yang K, Nishiwaki K, Mizobata H, Liang J, Asakawa S, et al. (2026) The Greenland shark genome: Insights into lifespan extremes and population dynamics. Proceedings National Acad Sci. 123(21):e2601272123.
46. Sahm A, Cherkasov A, Liu H, Voronov D, Hoffmann S. (2024) The Greenland shark (Somniosus microcephalus) genome provides insights into extreme longevity.
47. Yang K, Nishiwaki K, Mizobata H, Asakawa S, Yoshitake K, et al. (2025) The Greenland shark genome: insights into deep-sea ecology and lifespan extremes. BioRxiv.
48. Kirkwood T, Kapahi P, Shanley D. (2000) Evolution, stress, and longevity. J Anatomy. 197(Pt 4):587-90.
49. da Silva R, Conde DA, Baudisch A, Colchero F. (2022) Slow and negligible senescence among testudines challenges evolutionary theories of senescence. Science. 376(6600):1466-470.
50. Quesada V, Freitas-Rodríguez S, Miller J, Pérez-Silva JG, Jiang ZF, et al. (2019) Giant tortoise genomes provide insights into longevity and age-related disease. Nature Eco Evol. 3(1):87-95.
51. Wang H. (2020) Tortoise and Turtle Extension Lifespan in Related to Branched-Chain and Sulphur Contain Amino Acids: A Review. Biomed J Sci Tech Res. 28(2).
52. Wlaschek M, Singh K, Maity P, Scharffetter-Kochanek K. (2023) The skin of the naked mole-rat and its resilience against aging and cancer. Mechanisms Ageing Devel. 216:111887.
53. Ruby JG, Smith M, Buffenstein R. (2018) Naked mole-rat mortality rates defy Gompertzian laws by not increasing with age. Elife. 7.
54. Munro D, Baldy C, Pamenter ME, Treberg JR. (2019) The exceptional longevity of the naked mole‐rat may be explained by mitochondrial antioxidant defenses. Aging Cell. 18(3):e12916.
55. Kaeberlein MR, Martin GM. (2016) Handbook of the biology of aging. London Academic Press.
56. Zhang Z, Tian X, Lu JY, Boit K, Ablaeva J, et al. (2023) Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice. Nature. 1-10.
57. Illingworth CM. (1974) Trapped fingers and amputated finger tips in children. J Pediatric Surg. 9(6):853-58.
58. Dolan CP, Dawson LA, Muneoka K. (2018) Digit Tip Regeneration: Merging Regeneration Biology with Regenerative Medicine. STEM CELLS Trans Med. 7(3):262-70.
59. Miller TJ, Deptula PL, Buncke GM, Maan ZN. (2019) Digit Tip Injuries: Current Treatment and Future Regenerative Paradigms. Stem Cells Inte. 1-9.
60. Li Y, Tian X, Luo J, Bao T, Wang S, Wu X. (2024) Molecular mechanisms of aging and anti-aging strategies. Cell Communication and Signaling. 22(1).
61. Mescher AL, Neff AW. (2005) Regenerative Capacity and the Developing Immune System. In Regenerative Medicine I. 39-66.
62. Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, et al. (2010) Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proceedings of the National Academy of Sciences.
63. Slater G. (2019) Foetal Healing Cascade - Can We Duplicate It In Adults? Journal of Regenerative Biology and Medicine.
64. Einstein A. (1920) Relativity: the special and general theory. Methuen & Co Ltd.
65. Misner CW, Thorne KS, Wheeler JA. (1975) Gravitation [Book review]. Astronomische Nachrichten. 296(1).
66. Hafele JC, Keating RE. (1972) Around-the-World Atomic Clocks: Predicted Relativistic Time Gains. Sci. 177(4044):166-68.
67. Crimmins EM. (2015) Lifespan and Healthspan: Past, Present, and Promise. The Gerontol. 55(6):901-11.
68. Johnson S, Imai S. (2018) NAD+ biosynthesis, aging, and disease. F1000Research. 7.
69. Lyu YX, Fu Q, Wilczok D, Ying K, King A, et al. (2024) Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity. Aging. 16(20):12955-976.
70. Rando TA, Brunet A, Goodell MA. (2025) Hallmarks of stem cell aging. Cell Stem Cell. 32(7):1038-54.
71. Sun X, Kaufman PD. (2018) Ki-67: more than a proliferation marker. Chromosoma. 127(2):175-86.
72. Herzog C, Poganik JR, Barzilai N, Basisty N, Beerman I, et al. (2025). Biomarkers of Aging – NIA Joint Symposium 2024: New Insights into Aging Biomarkers. Aging Cell. 24(7).
73. Yan J, Chen S, Yi Z, Zhao R, Zhu J, et al. (2024) The role of p21 in cellular senescence and aging-related diseases. Mole Cells. 47(11):100113.
74. Moqri M, Herzog C, Poganik JR, Justice JN, Belsky DW, et al. (2023). Biomarkers of aging for the identification and evaluation of longevity interventions. Cell, 186(18):3758-75.
75. Lu AT, Binder AM, Zhang J, Yan Q, Reiner AP, et al. (2022). DNA methylation GrimAge version 2. Aging.
76. Tejada-Martinez D, de Magalhães JP, Opazo JC. (2021) Positive Selection and Gene Duplications in Tumour Suppressor Genes Reveal Clues about How Cetaceans Resist Cancer. Proceedings of the Royal Society B: Biological Sciences. 288(1945):20202592.